{"title":"SARS-COV-2 MRNA vaccine-associated cutaneous vasculitis.","authors":"Vedat Bugra Erol, Meryem Can","doi":"10.14744/nci.2022.22309","DOIUrl":null,"url":null,"abstract":"<p><p>During the coronavirus disease 2019 pandemic, global approach was to isolate populations with quarantine procedures to reduce the spread of this deadly virus until effective treatments are found or vaccines are developed. mRNA-based vaccines became available in the United States in March 2020. The Food and Drug Administration even issued an Emergency Use Authorization for individuals 16 years and older in December 2020. However, these rapid developments have brought along other problems such as possible side effects. As we develop and test a new treatment, it became clear how important side-effect management is. Here, we present a case of cutaneous vasculitis that developed on the fourth day of SARS-CoV-2 mRNA vaccination. The patient was successfully treated with medium-dose methylprednisolone.</p>","PeriodicalId":37802,"journal":{"name":"International Journal of Safety and Security Engineering","volume":"7 1","pages":"816-818"},"PeriodicalIF":0.0000,"publicationDate":"2023-11-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10846584/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Safety and Security Engineering","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.14744/nci.2022.22309","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"Engineering","Score":null,"Total":0}
引用次数: 0
Abstract
During the coronavirus disease 2019 pandemic, global approach was to isolate populations with quarantine procedures to reduce the spread of this deadly virus until effective treatments are found or vaccines are developed. mRNA-based vaccines became available in the United States in March 2020. The Food and Drug Administration even issued an Emergency Use Authorization for individuals 16 years and older in December 2020. However, these rapid developments have brought along other problems such as possible side effects. As we develop and test a new treatment, it became clear how important side-effect management is. Here, we present a case of cutaneous vasculitis that developed on the fourth day of SARS-CoV-2 mRNA vaccination. The patient was successfully treated with medium-dose methylprednisolone.
期刊介绍：
The International Journal of Safety and Security Engineering aims to provide a forum for the publication of papers on the most recent developments in the theoretical and practical aspects of these important fields. Safety and Security Engineering, due to its special nature, is an interdisciplinary area of research and applications that brings together in a systematic way many disciplines of engineering, from the traditional to the most technologically advanced. The Journal covers areas such as crisis management; security engineering; natural disasters and emergencies; terrorism; IT security; man-made hazards; risk management; control; protection and mitigation issues. The Journal aims to attract papers in all related fields, in addition to those listed under the List of Topics, as well as case studies describing practical experiences. The study of multifactor risk impact will be given special emphasis. Due to the multitude and variety of topics included, the List is only indicative of the themes of the expected papers. Authors are encouraged to submit papers in all areas of Safety and Security, with particular attention to integrated and interdisciplinary aspects.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
